Crédit Industriel et Commercial’s SpringWorks Therapeutics SWTX Stock Holding History

Crédit Industriel et Commercial’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-242,834	Closed	-$11.4M	–	429
2025 Q2	$11.4M	Buy	+242,834	New	+$10.8M	0.98%	27

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Crédit Industriel et Commercial's SWTX Position: Q3 2025 in Review

Crédit Industriel et Commercial sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 242,834 shares — an estimated $11.4M sold.

Crédit Industriel et Commercial first reported a position in SWTX in Q2 2025 and held it in 1 quarter. The position peaked at $11.4M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Crédit Industriel et Commercial reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Crédit Industriel et Commercial sold 242,834 SpringWorks Therapeutics shares in Q3 2025, an estimated $11.4M.
Crédit Industriel et Commercial first reported a position in SpringWorks Therapeutics in Q2 2025 and held it in 1 quarter.
Crédit Industriel et Commercial's SpringWorks Therapeutics position peaked at $11.4M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Crédit Industriel et Commercial's 13F filing for Q3 2025, filed 7 Nov 2025.